Page last updated: 2024-11-05

tranexamic acid and Uterine Diseases

tranexamic acid has been researched along with Uterine Diseases in 3 studies

Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.

Uterine Diseases: Pathological processes involving any part of the UTERUS.

Research Excerpts

ExcerptRelevanceReference
"Tranexamic acid is an antifibrinolytic agent that has shown to effectively reduce bleeding complications within other surgical and medical areas."2.82Anti-hemorrhagic effect of prophylactic tranexamic acid in benign hysterectomy-a double-blinded randomized placebo-controlled trial. ( Bergholt, T; Moeller, C; Ottesen, B; Ravn, P; Schouenborg, L; Settnes, A; Topsoee, MF, 2016)
"Dysfunctional uterine bleeding is defined as heavy menstrual uterine bleeding not due to any recognisable cause and is therefore a diagnosis of exclusion."2.42Dysfunctional uterine bleeding. ( Farrell, E, 2004)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Topsoee, MF1
Bergholt, T1
Ravn, P1
Schouenborg, L1
Moeller, C1
Ottesen, B1
Settnes, A1
Farrell, E1
Svanberg, L1
Astedt, B1

Clinical Trials (2)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Comparative Study For Role Of Different Prophylactic Doses Of Intravenous Tranexamic Acid In Reducing Blood Loss At Caesarean Section: A Randomised Controlled Trial[NCT02739815]Phase 4200 participants (Actual)Interventional2016-04-30Completed
Tranexamic Acid Versus Novel Uterine Cooling Technique in Reducing Blood Loss and Incidence of Postpartum Hemorrhage at Caesarean Section[NCT02780245]Phase 4100 participants (Actual)Interventional2016-06-30Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

1 review available for tranexamic acid and Uterine Diseases

ArticleYear
Dysfunctional uterine bleeding.
    Australian family physician, 2004, Volume: 33, Issue:11

    Topics: Antifibrinolytic Agents; Diagnosis, Differential; Female; Gynecologic Surgical Procedures; Humans; I

2004

Trials

1 trial available for tranexamic acid and Uterine Diseases

ArticleYear
Anti-hemorrhagic effect of prophylactic tranexamic acid in benign hysterectomy-a double-blinded randomized placebo-controlled trial.
    American journal of obstetrics and gynecology, 2016, Volume: 215, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Double-Blind Method;

2016
Anti-hemorrhagic effect of prophylactic tranexamic acid in benign hysterectomy-a double-blinded randomized placebo-controlled trial.
    American journal of obstetrics and gynecology, 2016, Volume: 215, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Double-Blind Method;

2016
Anti-hemorrhagic effect of prophylactic tranexamic acid in benign hysterectomy-a double-blinded randomized placebo-controlled trial.
    American journal of obstetrics and gynecology, 2016, Volume: 215, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Double-Blind Method;

2016
Anti-hemorrhagic effect of prophylactic tranexamic acid in benign hysterectomy-a double-blinded randomized placebo-controlled trial.
    American journal of obstetrics and gynecology, 2016, Volume: 215, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Double-Blind Method;

2016

Other Studies

1 other study available for tranexamic acid and Uterine Diseases

ArticleYear
Release of plasminogen activator from normal and neoplastic endometrium.
    Experientia, 1979, Jun-15, Volume: 35, Issue:6

    Topics: Endometrium; Female; Humans; Hyperplasia; Plasminogen Activators; Tranexamic Acid; Uterine Diseases;

1979